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Abstract
Purpose
Selective Decontamination of the Digestive tract (SDD) as a prophylactic intervention
improves hospital-acquired infection and survival rates. Uptake of SDD is low and remains
controversial. This study applied the Theoretical Domains Framework (TDF) to assess ICU
clinicians’ views about SDD in regions with limited or no adoption of SDD.
Materials and Methods
Participants were health professionals with ‘decisional authority’ for the adoption of SDD. Semi-
structured interviews were conducted as the first round of a Delphi study. Views about SDD
adoption, delivery and further SDD research were explored. Directed content analysis of interview
data identified sub-themes which informed item development for subsequent Delphi rounds.
Linguistic features of interview data were also explored.
Results
141 participants provided interview data. Fifty-six sub-themes were identified; 46 were common
across regions. Beliefs about consequences was the most widely elaborated theme. Linguistic
features of how participants discussed SDD included caution expressed when discussing the risks
and benefits and words such as worry, anxiety and fear when discussing potential antibiotic
resistance associated with SDD.
Conclusions
We identified salient beliefs, barriers and facilitators to SDD adoption and delivery. What
participants said about SDD and the way in which they said it demonstrated the degree of clinical
caution, uncertainty and concern that SDD evokes.
Background
Selective Decontamination of the Digestive tract (SDD) is an intervention used in intensive care
units. Evidence from randomised controlled trials suggests that it has significant potential to
reduce Hospital-Acquired Infections (HAIs). SDD involves the prophylactic application of topical
non-absorbable antibiotics to the oropharynx and stomach with a short course of intravenous
antibiotics. Despite much interest over many years and a large evidence base (36 randomised
controlled studies) suggesting efficacy in reducing rates of HAIs and increasing survival [1-9]
SDD has not been widely adopted into intensive care practice worldwide. SDD continues to be a
controversial subject, and seems to receive limited support from clinicians [10,11]. The multi-
national SuDDICU (Selective Decontamination of the Digestive tract in critically ill patients in
Intensive Care Units) mixed-methods research program [12] aimed to establish reasons for the
low adoption rate, barriers and facilitators to adoption of SDD and directions for further research.
Few published studies have examined healthcare professionals’ views about SDD, and those that
have do not use a theoretical framework [11,13]. This lack of a theoretical framework means that
findings cannot be used to build a cumulative evidence base or to inform an appropriate direction
for future research. This study aims to address this limitation by using a theoretical framework
developed for investigating the determinants of healthcare professional behaviour; the Theoretical
Domains Framework (TDF) [14]. The TDF, which integrates behavioural theories, was developed
through a consensus process with health psychologists and health services researchers to
systematically assess the behaviour change processes inherent to implementation of evidence-
based practice. The TDF proposes that the determinants of healthcare professionals’ behaviour
cluster into 12 ‘domains’ (such as ‘social influences’, ‘beliefs about consequences’,
social/professional role and identity’). The content of each of the domains is described in Table 1.
The controversial nature of SDD and the uncertainty about its evidence base [1-9,15,16] suggests
that clinicians both within and between different clinical specialities and professional groups may
hold opposing views. This study therefore applied Delphi methodology to systematically assess
agreement/disagreement with SDD within ICU healthcare professionals. The Delphi method is a
structured iterative process which gauges views from a panel of experts (or key stakeholders) and
involves multiple, sequential ‘rounds’ [17]. Originally developed as a method to achieve
consensus [18], it can also be used as a way to assess levels of agreement/disagreement [19]. The
Delphi study investigated views of ICU healthcare professionals working in three regions with
limited or no adoption of SDD (the UK, Canada and Australia/New Zealand). We investigated
views about SDD adoption and whether further SDD research is needed, ethical, acceptable and
feasible. The Delphi study commenced with a qualitative round to identify the range of views. The
findings from this first round were then used to develop two quantitative questionnaire rounds to
assess stability of healthcare professionals’ views and the level of consensus within and between
ICU healthcare professional groups [20]. This paper describes the findings from the first Delphi
round, the semi-structured interviews, and reports on (i) what ICU healthcare professionals said
about SDD and (ii) how they spoke about SDD.
The TDF was designed for investigating behaviours of individual healthcare professionals when
either the target actions are recommended by a clinical guideline or when the evidence base in
favour of a certain action is clear. To our knowledge, this is the first study to use the TDF to
investigate an intervention that (a) would be adopted and delivered at the Unit level in a hospital
context (rather than by individuals), and (b) where there is uncertainty about the evidence base.
We aimed to identify the range of beliefs, interpretation and views about the current evidence base
relating to the use of SDD in key stakeholder groups and answer the following research questions:
(1) What are the views of key stakeholders of the internal / external validity and adequacy of the
existing evidence base for SDD, and how willing are they to participate in further research? (2)
What are the views of key stakeholders about the likely positive and negative consequences of
implementing SDD in ICUs? (3) What are the views of key stakeholders about the likely barriers
to implementing SDD in ICUs?
Methods
This study was part of the multi-national SuDDICU mixed-methods research program.  Full study
design and methods are published  elsewhere  [12].  In  brief,  the  SuDDICU  collaboration  is  an
international  investigator-initiated  independent  research  collaboration   that   has   assessed   the
evidence base and outcomes for the use of SDD and the risks, benefits, and barriers to its use.
Participants and sampling
The sample consisted of key stakeholders most likely to have ‘decisional authority’ for the
adoption/or delivery of SDD within ICUs from three geographical regions (UK, Canada and
Australia/New Zealand). We recruited healthcare professionals from four groups; (i) intensive
care physicians (hereafter referred to as ‘intensivists’), (ii) intensive care pharmacists (hereafter
referred to as ‘pharmacists’), (iii) clinical microbiologists/infectious disease physicians with
intensive care responsibility (hereafter referred to as ‘microbiology/ID physicians’), and (iv)
intensive care leads (including medical leads, nurse managers and senior ICU nurses).
Purposive sampling was used to achieve sample diversity according to predetermined factors
(geographical location, ICU size, academic affiliation). In line with recommended Delphi sample
sizes [21], we aimed to retain ten participants per stakeholder group within each region by the end
of the Delphi rounds (i.e. 120 participants in total). Using purposively sampling and allowing for
attrition, we over-recruited (over 10 per group), so that we ultimately sampled approximately 13
participants, per group, in each of the 4 groups for each geographical zone.  No participant who
was approached and agreed to participate was declined participation.
Materials
A semi-structured interview topic guide was designed through an iterative process by the
international research team. The topic guide was designed to elicit beliefs within all domains of
the TDF alongside questions about willingness to participate in, and the need for, further SDD
research. The topic guide was piloted in each region with one representative from each of the four
stakeholder groups who was not part of the sample to assess face validity, clarity and time for
completion. Minor edits were made to the topic guide following piloting to clarify wording. The
topic guide is presented in Additional File 1. To ensure a shared understanding of SDD,
participants were first asked to give their definition of SDD and then requested, for the remainder
of the interview, to consider SDD as “the application of antibiotics in three ways; orally, to the
mouth and throat, gastric application to the stomach and a short course of IV antibiotics”. This
definition is based on the most commonly applied SDD regimen in clinical studies and practice as
well as the largest trial to date on the subject [16].
Procedure
Experts in each of the four stakeholder groups were identified by clinicians on the SuDDICU
project team and through databases of existing clinical networks.  Recruitment procedures are
reported in full elsewhere [12,20].  Research teams in each geographical region conducted
interviews by telephone which were recorded and transcribed verbatim. Transcripts were checked
for accuracy against interview recordings and anonymised.
Analysis
First, analysis focused on what participants said about SDD. Interview content was  independently
coded by two researchers into sub-themes using directed content  analysis[22].  A  sub-theme  was
defined as a statement whose content may  indicate  a  perceived  influence  on  SDD  adoption  or
delivery. Sub-themes that expressed the same theme or were polar  opposites  of  the  same  theme
were grouped together and were considered as repeats of the same  sub-theme.  This  analysis  was
performed using an iterative and  parallel  process  with  the  UK  ,  Canada  and  Australia  /  New
Zealand SUDDICU researchers (who had adopted an identical topic guide and sampling strategy).
 The next stage in the analysis involved grouping  of  the  sub-themes  into  ‘overarching  themes’,
which were the pre-specified TDF domains (and an additional  ‘further  research’  category).  This
was carried out independently by two researchers using the TDF  as  an  analytic  framework,  and
content analysis methods previously employed by the research  team  in  the  context  of  intensive
care [23].  Where  there  was  disagreement  between  coders  these  were  discussed  with  a  third
researcher. Similarities and  differences  in  the  views  expressed  across  the  three  regions  were
explored.
Second, further qualitative analysis was carried out at a more interpretive level [24] to analyse
how participants spoke about SDD (i.e. the linguistic features of the data).  This analysis step
focussed on the ‘beliefs about consequences’ domain sub-themes as this was the domain most
widely elaborated by participants and involved clinical judgements about likely benefits and risks.
Two researchers (ED and MP) independently examined the linguistic features of the data to
enhance understanding of the breadth and depth of views coded within each sub-theme, and the
similarities and differences between the manner in which participants spoke about their beliefs
were considered.
Ethics
Each region obtained separate research ethics approval: UK North of Scotland Research Ethics
Service, reference 10/S0801/69, approval date 24 November 2010; Research Ethics Board of
Sunnybrook Health Sciences Centre, reference 306-2010, approval date October 18, 2010;
Nepean Blue Mountains Local Health Network Human Research Ethics Committee, HREC No.
11/08, 17 March 2011.
Results
Participant characteristics
Two hundred and forty-six clinicians were invited to participate and 141 (from 84 hospitals)
accepted (57% response rate). Participants’ mean age and years of experience were comparable
across the three regions (Table 2).
The results are presented in two sections below relating to what and how participants discussed
SDD.  Following this, we present results of the item generation process for the quantitative
questionnaire rounds of the Delphi study.
What participants said about SDD
An overview of sub-theme content is given below under the 12 domain headings of the TDF [14];
for illustrative quotes please see Additional File 2.
1. Beliefs about consequences
Both positive and negative consequences of SDD were identified. A widely discussed concern
was that SDD potentially leads to the development of antibiotic resistance. Concerns were also
raised about the potential for SDD to increase the risk for Clostridium difficile. The potential
benefits of delivering SDD were described; including reduction in rates of Ventilator Associated
Pneumonia (VAP) and length of stay (in ICU and/or hospital). However, some participants
expressed scepticism about the benefits of SDD, particularly a mortality benefit. The importance
of weighing the risks and benefits of SDD was stressed, for example, whether potential decreases
in mortality and VAP are worth the risk of increased antibiotic resistance.  Some concern was
expressed that the delivery of SDD would increase nurses’ workload, however, this perception
was not reported by any of the nurse participants. Financial outcomes were also discussed
including the potential for cost-savings (due to reducing VAP and length of stay), but also the
potential for an increase in financial costs (due to the cost of drugs and the human resources that
might be required).
2. Memory, attention and decision processes
Participants discussed the decision processes to enable SDD adoption. The importance of
assessing the available literature and adopting a team-based approach was emphasized. The need
for ‘buy-in’ of professional groups was identified with variation across regions as to which
professions would need to buy in.  For example, in Australia/New Zealand and Canada, nursing
buy-in was perceived to be crucial but this professional group was not singled out by UK
participants.
3. Knowledge
Participants were broadly aware of what delivery of SDD entails and most had some
knowledge of the evidence relating to SDD. However, some were uncertain about which patient
groups should receive SDD. In addition, dissatisfaction with the existing evidence base was
reported, with the length of follow-up in randomised trials being a particular issue. Longer-term
studies were perceived necessary to assess the potential impact of SDD on the development of
antibiotic resistance.
4. Motivation and goals
Some participants reported that SDD was not a salient issue for them and was not a topic of
discussion in their units or among their colleagues. Participants expressed the belief that VAP was
already adequately addressed by other interventions and therefore were not motivated to pursue
other options such as SDD. In addition, some perceived other clinical priorities as more important
at the present time, for example, ensuring that the existing VAP bundle procedures were properly
delivered. Finally, there were some reports that SDD was considered “old news” and no longer a
relevant clinical topic but contrasting views were also expressed.
5. Environmental context and resources
The environmental context of the current evidence base was raised as a concern by some
participants. It was felt that, compared with the Netherlands where most of the evidence has been
generated, there are national differences in patient characteristics, ICU ecology/microbial flora,
and standards of care that limit generalisability. Other resource and contextual issues concerned
the need for additional educational and financial resources and the need to have pre-prepared
pastes available.
6. Professional role and identity
Some participants reported that SDD conflicted with their professional obligations, i.e. giving
prophylactic antibiotics when it was a professional duty to reduce antibiotic use. For some, the
perception was that professional groups (microbiology/ID physicians) hold conflicting opinions
on antibiotic use that could influence SDD adoption.
7. Behavioral regulation
Many participants noted that current national and international guidelines on infection control do
not have a clear position on SDD and this absence of recommendations was perceived to influence
willingness to adopt SDD.
8. Social influences
Participants suggested that adoption would require a clinical champion or SDD expert to put SDD
on the agenda, educate others and drive SDD forward. Some also felt that their practice was
influenced by the practices of other ICUs.  Specifically they felt reassured that their position to not
deliver SDD was in line with other ICUs.
9. Skills
Participants reported that ICU staff already have the necessary skills to deliver SDD.
10. Nature of the behaviors
The behaviours involved in SDD delivery were not judged overly complex or an important barrier
to SDD adoption.
11. Beliefs about capabilities
As would be expected given the sampling strategy, many participants felt confident in their own
ability to influence SDD adoption and/or delivery.  However, some non-intensivists did not share
this confidence.
12. Emotion
Emotional factors were not considered to be barriers to adopting SDD.
Views on further research
Although not a domain from the TDF, participants were also explicitly prompted to discuss their
views on participating in further SDD research specifically the need to: a) investigate the
effectiveness of SDD (i.e. in a RCT); b) test implementation strategies to encourage uptake of
SDD. Most participants expressed willingness to support an effectiveness trial of SDD. Some
participants, however, felt that enough research had already taken place to provide the evidence to
make a decision on SDD adoption. Those participants supporting the need for future research
indicated it should include: (1) longer follow up of antibiotic resistance than previous studies; (2)
a control group comprising current standards of care; and (3) a cost-benefit analysis.  Most
participants were less willing to support an implementation trial, in part, due to insufficient
evidence on effectiveness.
As displayed in Additional File 1, there was substantial consistency in the sub-themes across the
three geographical regions. Forty-six of the fifty-six sub-themes identified emerged in all three
geographical regions.
The findings reported above describe what participants said about SDD. The following section
describes how they said it.  We describe the inferences that we have drawn from analysis of some
of the linguistic features of the interview data.
How participants discussed the consequences of SDD
There were interesting findings relating to the linguistic features of the transcripts within the data
coded as ‘beliefs about consequences’. Two major findings were identified: (i) the clinical caution
and uncertainty expressed, and (ii) the language of concern used by participants to discuss risks of
SDD.
Clinical caution and uncertainty
Commonly used language when discussing benefits and risks of SDD included terms such as
‘probable’, ‘possible’, ‘proposed’, ‘supposed’, ‘hoped’.  For example, when discussing the benefit
of reduced HAIs:
I guess by delivering SDD it may well be that we can decrease the incidence of
particularly Gram-negative pathogens in the intensive care I’m not so sure about Gram-
positives.  It would hopefully be that we have less colonization.  (ANZ interviewee 211)
Similar language of uncertainty was used when discussing the impact of SDD on length of
patients’ stay in hospital/ICU and the impact on mortality;
Now I suppose what you would envisage is that if you have fewer infections, patients
may stay ventilated for shorter periods of time and may have a shorter length of stay, so
conceivably those would be the benefits in terms of financial benefits (UK Interviewee 23)
However, the potential benefit of SDD to decrease VAP seemed to be discussed in more certain
terms. For example;
Certainly the evidence at that time showed it reduced pneumonia, no question (CA
Interviewee 127)
The language of concern
The type of language interviewees used in their discussions about the potential for SDD to
increase antibiotic resistance highlighted underlying concerns.  Participants used words such as
‘concern’, ‘worry’, ‘anxiety’ and ‘fear’ when discussing the issue of antibiotic resistance.  For
example,
We are quite afraid of the risk of bacterial resistance with the use of antibiotics (CA
Interviewee 120)
Microbiology/ID Physicians were identified by some interviewees as being a particular
professional group with concerns;
“my microbiology friends, I think, are worried about the emergence of resistance” (UK
Interviewee 32)
Generation of questionnaire items for later Delphi rounds
Across the 141 transcripts, data were coded in to all 12 of the TDF domains and the ‘further
research’ theme and we identified 54 sub-themes. The sub-themes formed the basis of
questionnaire items for the subsequent Delphi rounds [12] and are presented in Additional File 1
alongside illustrative quotes. As shown in Additional File 1, the ‘beliefs about consequences’
domain theme was the most elaborated in the interviews and therefore had the greatest number of
sub-themes. We present an example of coding into a TDF domain theme (‘beliefs about
consequences’) and sub-themes in Table 3. Although sub-themes are worded as questionnaire
items which indicate one direction of belief (e.g. ‘I am opposed to SDD’), all negative, positive
and neutral utterances of a belief (e.g. ‘I am in favour of SDD’ and ‘I have no strong feelings
about SDD’) were coded together and generated one questionnaire item. The questionnaire items
were framed to provide a balance of item direction (i.e. favourable to SDD, unfavourable to SDD
or neutral), to avoid a pro-SDD bias and to reflect good practice in constructing questionnaire
items.
Discussion
This study provides a qualitative perspective on ICU healthcare professionals’ views about SDD
in regions where SDD is not commonly used.  Participants’ views indicated a number of barriers
to the adoption of SDD; the most widely discussed being in the TDF domain ‘beliefs about
consequences’. A great many of the sub-themes were held in common across all three
geographical regions. Therefore, there appeared to be substantial consistency in the views raised
about SDD across these three distinct regions.
The ICU healthcare professionals interviewed in this study displayed a degree of clinical caution
and uncertainty when talking about potential benefits such as SDD reducing HAIs, improving
mortality rates or reducing the length of patients’ stay in hospital. There appeared to be more
certainty expressed about the effects of SDD on VAP but, for other benefits and risks, uncertainty
prevailed. Further examination of uncertainty was included within the later rounds of the Delphi
study [20]. The risk of SDD contributing to increased antibiotic resistance was extensively
discussed and interviewees used the language of concern, expressing worry, anxiety and fear. This
fear would seem to be upheld by the existing evidence on antibiotic resistance [7-9].
These findings help us understand why the implementation of SDD has been low in most areas of
the world. Despite one of the larger evidence bases in the field of critical care, the impact of the
evidence is low. It is clear from these results that, although clinicians’ knowledge of the evidence
base could be improved, fear of driving antibiotic resistance is a major limiting factor that needs
to be more clearly understood before clinicians will implement this regimen [7-9]. It is fascinating
to reflect that an evidence base suggesting effectiveness in 36 RCT amassed over a 30 year period
[1-6] is not compelling enough to overcome a perceived risk of driving antibiotic resistance that,
to date, has not been upheld in the existing literature [7-9].
The interview topic guide was based on a theoretical framework of clinical behaviour [14] which
ensured good coverage of potential barriers and facilitators to SDD adoption. However, a
limitation of the study is that using the TDF meant that there was a trade-off between prompting
participants using closed questions to cover all domains, and using open questions which could
provide richer data for qualitative analysis. Nevertheless, the topic guide did provide data suitable
for qualitative analysis (including the data coded under ‘beliefs about consequences’ from which
the linguistic findings are based) and the results add to previous research which has employed a
purely quantitative approach [11,13] and was not theory-based.
Previous research investigating views towards SDD and barriers is limited [11,13]. A study from
the Netherlands mainly looked at work load and “patient friendliness” of SDD and identified that
SDD increased workload for nurses and doctors and was less patient friendly [13].  Similarly we
identified concerns about increased nursing workload in this study. However this was not
expressed by nursing participants. Findings relating to the nursing participants are elaborated in a
separate publication [25].
A UK survey identified that the main factors preventing wider spread use of SDD in UK practice
was lack of supportive evidence base and concerns about antibiotic resistance [11].  In the current
study we identified issues relating to the clarity as opposed to the lack of evidence and a perceived
need for more effective communication of the evidence base to clinicians.
Our study has a number of strengths. Firstly is its theoretical basis, the TDF which enables a
wider range of barriers to be identified than participants might otherwise report [26]. Second is
that using the TDF as a basis allows for the results to be linked to an evidence base for
intervention design [27] if appropriate. Domains identified as problematic could be linked to
theory-based intervention techniques to change behaviour [27]. Third is the inclusion of
participants from three geographical areas, and four professional groups. Previous research
examining ICU health professionals’ views has focused on views within a single country and has
not included all professions identified in this study as key stakeholders in the decision to adopt
SDD. Limitations of the study include the potential for selection bias as participants self-selected
to participate in the study. This is common to all such studies but in this situation could lead to
two possible effects: 1. Clinicians in favour of SDD more commonly participate in the study and
this biases the study in favour of a more positive view on SDD; 2. Clinicians with strong views
against SDD more commonly participate in the study and this biases the study in against SDD.
We are unable to identify participants’ beliefs prior to this study but since so few utilise SDD in
their practice, option 1 above seems less likely.
The language used in discussions about antibiotic resistance suggests that any future SDD
implementation efforts would need to address the concern this issue holds for ICU healthcare
professionals. The uncertainty evident in the interviewees’ discussions about the risks and benefits
of SDD suggests that either clinicians feel that the current evidence base for SDD is unclear, or
that efforts are needed to communicate the evidence base to clinicians more clearly. Further
research could explore these linguistic findings in more depth using a discourse analysis approach.
Conclusions
This is the first time the TDF has been used within a Delphi study and to explore an intervention
when there is uncertainty about the evidence base and no clear guidelines on action. Using the
framework resulted in identification of salient beliefs and the barriers and facilitators to adoption
and implementation of SDD. Examining both what participants said about SDD and the way in
which they said it was instructive and demonstrated clearly the degree of clinical caution,
uncertainty and concern that SDD evokes. This study adds to the existing evidence base in
identifying that clinicians’ beliefs about the consequences of SDD affect their perception of the
balance of risks and benefits for SDD, with a very clear expression of concern about the effects of
SDD on antibiotic resistance.
Abbreviations
ANZ – Australia/New Zealand
CA – Canada
HAI – Hospital-Acquired Infections
ICU – Intensive Care Unit
ID – Infectious Diseases
SDD – Selective Decontamination of the Digestive tract
SuDDICU – Selective Decontamination of the Digestive tract in critically ill patients in Intensive
Care Units
TDF – Theoretical Domains Framework
UK – United Kingdom
VAP – Ventilator Associated Pneumonia
Authors’ contributions
EMD conducted the UK interviews and analysis, contributed to the international analysis and lead
on the writing of the manuscript.  BHC conceived of the study, participated in its design and
coordination, contributed to the interpretation of the data, and participated in drafting the
manuscript.  MEP conducted the UK interviews and analysis, contributed to the international
analysis and participated in drafting the manuscript. APM conducted the Australian/New Zealand
interviews and analysis and participated in revising the manuscript. ECW, LET, conducted the
Canadian interviews and analysis and participated in revising the manuscript. DB conducted the
UK analysis, and participated in revising the manuscript. RSN and FW conducted the Canadian
analysis and participated in revising the manuscript. LR, MKC, GB, IMS conceived of the study,
participated in its design and coordination, contributed to the interpretation of the data and
participated in reviewing the manuscript.  JJF conceived of the study, led its design and
coordination, contributed to the analysis and interpretation of the data, and participated in drafting
and reviewing of the manuscript. All authors approved the final manuscript.
Acknowledgements
The SuDDICU collaboration is a collaboration of the Canadian Critical Care trials group
(CCCTG) and the Australia and New Zealand Intensive Care Society Clinical Trials Group
(ANZICS CTG) and is supported by the both organisations.
This project was funded in the UK by the NIHR Health Technology Assessment programme and
will be published in full in the Health Technology Assessment journal series. Visit the HTA
programme website for more details www.hta.ac.uk/2299. The views and opinions expressed
therein are those of the authors and do not necessarily reflect those of the Department of Health.
We acknowledge the support of a Canadian Institutes of Health Research operating grant that
funded the Canadian study. We acknowledge the support of an Australian Intensive Care
Foundation grant that part funded the Australia and New Zealand study. We acknowledge the
support of the Australian and New Zealand College of Anaesthetists grant that part funded the
Australia and New Zealand study.
The Health Services Research Unit at the University of Aberdeen is core funded by the Chief
Scientist Office of the Scottish Government Health Directorates. Views expressed are those of the
authors and do not necessarily reflect the view of the Chief Scientist Office.
The SuDDICU International collaboration includes-
SuDDICU UK study group- Jill  Francis,  City  University  London;  Geoff  Bellingan,  University
College Hospital; Marion Campbell,  University  of  Aberdeen,;  Brian  Cuthbertson,  Sunnybrook
Health Sciences Centre; Eilidh Duncan, University  of  Aberdeen,;  Martin  Eccles,  University  of
Newcastle; Graeme MacLennan, University of Aberdeen,; Maria  Prior,  University  of  Aberdeen;
Louise Rose, University of Toronto,; Kathy Rowan, Intensive Care National  Audit  and  Research
Committee;  Rob  Shulman,  University  College  Hospital,;  Peter   Wilson,   University   College
Hospital
SuDDICU Canada  study  group-  Brian  Cuthbertson,  Sunnybrook  Health  Sciences  Centre;  Jill
Francis,  City  University  London,  UK;  Karen  Burns,  St  Michaels  Hospital;   Deborah   Cook,
McMaster  University;  Peter  Dodeck,  St.  Paul’s  Hospital,;  Niall  Ferguson,  University  Health
Network;  Jeremy  Grimshaw,  Ottawa   Health   Research   Institute,;   Richard   Hall,   Dalhousie
University  and  The  Queen  Elizabeth  II  Health  Sciences  Centre;  Lynn   Johnston,   Dalhousie
University; Salmann Kanji, The Ottawa Hospital; John Marshall, St Michaels  Hospital;  Lauralyn
McIntyre, Ottawa Health  Research  Institute;  John  Muscedere  Kingston  General  Hospital;  Joe
Pagliarello, University of Ottawa; Louise RoseUniversity of Toronto; Laura  Todd,  University  of
Toronto; Fiona Webster, University of Toronto;  Charles  Weijer,  Western  University;  Elisabeth
Wells, Sunnybrook Health Sciences Centre.
SuDDICU Australia  and  New  Zealand  Study  Group-  Ian  Seppelt,  Nepean  Hospital,  and  the
George Institute for  Global  Health,  Sydney;  Brian  Cuthbertson,  Sunnybrook  Health  Sciences
Centre;  Louise  Cole,  University  of  Sydney;  Arina  Dan,   The   George   Institute   for   Global
Health,; Simon Finfer, Royal North Shore Hospital  and  the  George  Institute;  Jill  Francis,  City
University London, UK; Jeff Lipman, Royal Brisbane and  Women’s  Hospital;  Andrea  Marshall,
Griffith University  and  Gold  Coast  Hospital  and  Health  Service;  John  Myburgh,  St  George
Hospital Sydney and the George Institute for Global Health; David Paterson, Royal Brisbane and
Women’s Hospital, University of Queensland; Leonie Weisbrodt, Nepean Hospital.
References
[1] Silvestri L, van Saene HK, Milanese M, et al: Selective decontamination of the digestive tract
reduces bacterial bloodstream infection and mortality in critically ill patients. Systematic review
of randomized, controlled trials. J Hosp Infect. 65: 187-203, 2007
[2] Silvestri L, van Saene HK, Milanese M, et al: Impact of selective decontamination of
the digestive tract on fungal carriage and infection: systematic review of randomized
controlled trials. Intensive Care Med. 31: 898-910, 2005
[3] Liberati A, D’Amico R, Pifferi S, et al: Antibiotic prophylaxis to reduce respiratory tract
infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev.
Issue 4: Art. No.: CD000022. DOI: 10.1002/14651858.CD000022.pub3., 2009
[4] de Jonge E, Schultz MJ, Spanjaard L, et al: Effects of selective decontamination of
digestive tract on mortality and acquisition of resistant bacteria in intensive care: a
randomised controlled trial. Lancet. 362: 1011-1016, 2003
[5] Oostdijk EAN, De Smet AMGA, Bonten MJM, et al: Effects of decomntamination of
the digestive tract and oropharynx in intensive care unit patients on 1-year survival. Am J
Respir Crit Care Med. 188: 117-120, 2013
[6] de Smet AM, Kluytmans JA, Blok HE, et al: Selective digestive tract decontamination
and selective oropharyngeal decontamination and antibiotic resistance in patients in
intensive-care units: an open-label, clustered group-randomised, crossover study. The
Lancet Infectious Diseases. 11: 372-380, 2011
[7] Daneman N, Sarwar S, Fowler RA, et al: Effect of selective decontamination on
antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
The Lancet Infectious Diseases. 13: 328-341, 2013
[8] Houben AJM, Oostdijk EAN, van der Voort PHH, et al: Selective decontamination of
the oropharynx and the digestive tract and antimicrobial resistance: a 4 year ecological
study in 38 intensive care units in the Netherlands. Journal of Antimicrobial
Chemotherapy. 69: 797-804, 2014
[9] Oostdijk EAN, De Smet AMGA, Blok HEM, et al: Ecological effects of selective
decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care
Med. 181: 452-457, 2010
[10] Vincent J, Jacobs F: Effect of selective decontamination on antibiotic resistance. The
Lancet. 11: 337-338, 2011
[11] Bastin AJ, Ryanna KB: Use of selective decontamination of the digestive tract in
United Kingdom intensive care units. Anaesthesia. 64: 46-49, 2009
[12] Cuthbertson BH, Francis J, Campbell MK, et al: A study of the perceived risks,
benefits and barriers to the use of SDD in adult critical care units (The SuDDICU study).
Trials. 11: 117, 2010
[13] Jongerden IP, de Smet AM, Kluytmans JA, et al: Physicians’ and nurses’ opinions on
selective decontamination of the digestive tract and selective oropharyngeal
decontamination: a survey. Crit Care. 14: R132, 2010
[14] Michie S, Johnston M, Abraham C, et al: Making psychological theory useful for
implementing evidence based practice: a consensus approach. Qual Saf Health Care.
14: 26-33, 2005
[15] Stoutenbeek CP, van Saene HK, Little RA, et al: The effect of selective
decontamination of the digestive tract on mortality in multiple trauma patients: a
multicenter randomized controlled trial. Intensive Care Med. 33: 261-270, 2007
[16] de Smet AM, Kluytmans JA, Cooper BS, et al: Decontamination of the digestive tract
and oropharynx in ICU patients. N Engl J Med. 360: 20-31, 2009
[17] Dalkey NC, Helmer O: An experimental application of the Delphi method to the use
of experts. Manage Sci. 9: 458-467, 1963
[18] Dalkey NC: The Delphi method: an experimental study of group opinion. , 1969
[19] Park RE, Fink A, Brook RH, et al: Physician ratings of appropriate indications for
three procedures: Theoretical indications vs indications used in practice. Am J Public
Health. 79: 445-447, 1989
[20] Francis JJ, Duncan EM, Prior ME, et al: Selective Decontamination of the Digestive
tract in critically ill patients treated in Intensive Care Units: a mixed-methods feasibility
study (the SuDDICU study). Health Technology Assessment. , in press
[21] Akins RB, Tolson H, Cole BR: Stability of response characteristics of a Delphi panel:
Application of bootstrap data expansion. BMC Med Res Method. 5, 2005
[22] Hsieh HF, Shannon SE: Three approaches to qualitative content analysis. Qual
Health Res. 15: 1277-1288, 2005
[23] Francis JJ, Stockton C, Eccles MP, et al: Evidence-based selection of theories for
designing behaviour change interventions: Using methods based on theoretical construct
domains to understand clinicians’ blood transfusion behaviour. Brit J Health Psy. 14: 625-
646, 2009
[24] Ritchie J: The Applications of Qualitative Methods to Social Research, in Ritchie J,
Lewis J (eds): Qualitative Research Practice. London, Sage Publications Ltd., 2003, pp
24-46
[25] Marshall AP, Weisbrodt L, Rose L, et al: Implementing selective digestive tract
decontamination in the intensive care unit: A qualitative analysis of nurse-identified
considerations. Heart & Lung. 43: 13-8, 2014
[26] Dyson J, Lawton R, Jackson C, et al: Does the use of a theoretical approach tell us
more about hand hygiene behaviour? The barriers and levers to hand hygiene. J Infect
Prev. 12: 17-24, 2011
[27] Michie S, Johnston M, Francis JJ, et al: From theory to intervention: mapping
theoretically derived behavioural determinants to behaviour change techniques. Appl
Psychol. 57: 660-680, 2008
